A risky combination of medicines gets riskier when a patient’s prescriptions come from two doctors

For years, experts have warned of the risks of combining certain sedatives and prescription pain medications—for instance, Xanax and Vicodin, Valium and Norco, or Restoril and Percocet. Now, a new study shows that this combination is especially risky if multiple doctors prescribe the two different types of drugs to the same patient rather than the […]

Continue Reading

Study: Dual treatment of chronic lung diseases increases risk of heart attack

People using two different inhalers for common chronic lung diseases are more than 50 percent more likely to have a heart attack than those on just one, new University of Otago-led research reveals. Inhaled long-acting muscarinic antagonists (LAMAs) and long-acting beta-agonists (LABAs) are the main drugs used to treat chronic obstructive pulmonary disease (COPD) – […]

Continue Reading

Researchers develop regenerative, safe therapeutic for Alzheimer’s disease

University of Arizona researchers have developed a new therapy for Alzheimer’s disease designed to restore cognitive function in early-stage patients. The therapy is now proceeding through a Phase 2b clinical trial. Phase 2b trials involve rigorous testing for efficacy in groups of 100 to 300 patients. The team, led by Roberta Diaz Brinton, director of […]

Continue Reading

Researchers unlock genetic ‘treasure map’ for chronic kidney disease

Despite impacting an estimated 850 million people and being responsible for 1 in 60 deaths worldwide, few treatments are available for chronic kidney disease. Understanding the genetic variations associated with the disease represents an important step for drug development. Now, in one of the most comprehensive genome-wide association studies of its kind, researchers in the […]

Continue Reading